Filing Flows › Kestra Medical Technologies (KMTS) › Q3 FY25
Kestra Medical Technologies (KMTS) Q3 FY25 earnings results (third quarter fiscal 2025)
10-Q filed Apr 17, 2025
Kestra Medical Technologies (KMTS) reported revenue of $15.1M for the third quarter fiscal 2025 (Q3 FY25) and +3% from the quarter before. Operating margin was -136.5%, net loss $21.8M (144.2% of revenue).
Kestra Medical Technologies, Q3 FY25: revenue $15.1M, operating margin -136.5%, net loss $21.8M, operating cash flow −$18.0M. The chart follows the revenue to costs, profit and cash.
| Q3 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.1M | +3% | — |
| Operating profit | −$20.6M | — | — |
| Net earnings | −$21.8M | — | — |
| Operating cash flow | −$18.0M | — | — |
What changed
Revenue was $15.1M in Q3 FY25, up 3% from the previous quarter.
Gross margin was 43.4%. Operating costs exceeded revenue by $20.6M, an operating margin of -136.5%. The quarter ended with a net loss of $21.8M, wider than the previous quarter's $20.6M loss. Minority interests bore $250K of it: to shareholders the quarter was a loss of $21.5M.
Operating cash flow was −$18.0M. Non-cash charges added back $1.9M of depreciation and $459K of share-based compensation. Working capital and other items added $1.4M. Capital expenditures of $4.1M exceeded it, leaving free cash flow of −$22.1M.
Questions
What was Kestra Medical Technologies' revenue in the third quarter fiscal 2025?
Kestra Medical Technologies (KMTS) reported revenue of $15.1M for the third quarter fiscal 2025 (Q3 FY25) and +3% from the quarter before.
Was Kestra Medical Technologies profitable in the third quarter fiscal 2025?
Operating loss was $20.6M (-136.5% of revenue) and net loss $21.8M.